Technical Analysis for SYN - Synthetic Biologics, Inc.

Grade Last Price % Change Price Change
grade F 0.55 -0.36% 0.00
SYN closed down 0.36 percent on Friday, May 24, 2019, on 20 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical SYN trend table...

Date Alert Name Type % Chg
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -0.36%
Down 3 Days in a Row Weakness -0.36%
Down 4 Days in a Row Weakness -0.36%
Down 5 Days in a Row Weakness -0.36%
Lower Bollinger Band Touch Weakness -0.36%
Oversold Stochastic Weakness -0.36%

Older signals for SYN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Synthetics Biologics, Inc., a biotechnology company, focuses on the development of biologics for the prevention and treatment of serious infectious diseases. The company's product candidates include Trimesta, which is in Phase II clinical trial for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis; SYN-004, which is in Phase II clinical trial for the treatment of clostridium difficile infection prevention; SYN-005, which is in preclinical stage for the treatment of pertussis; and SYN-001, which is in discovery stage for the treatment of acinetobacter infection. It has an agreement with Meda AB for the development and commercialization of Effirma (flupirtine) for fibromyalgia in the United States, Canada, and Japan, as well as with The University of Texas at Austin, Intrexon Corporation, and the Regents of the University of California. The company was formerly known as Adeona Pharmaceuticals, Inc. and changed its name to Synthetics Biologics, Inc. in February 2012. Synthetics Biologics, Inc. was founded in 2001 and is based in Rockville, Maryland.
Biotechnology Infectious Diseases Chemical Compounds Multiple Sclerosis Pyridines Carbamates Clostridioides Difficile Clostridium Difficile Infection Fibromyalgia Relapsing Remitting Multiple Sclerosis University Of California Cognitive Dysfunction Flupirtine Microorganisms
Is SYN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 318.5
52 Week Low 0.51
Average Volume 195,828
200-Day Moving Average 2.5632
50-Day Moving Average 0.6291
20-Day Moving Average 0.5914
10-Day Moving Average 0.5687
Average True Range 0.032
ADX 12.02
+DI 13.5487
-DI 17.1377
Chandelier Exit (Long, 3 ATRs ) 0.554
Chandelier Exit (Short, 3 ATRs ) 0.636
Upper Bollinger Band 0.6456
Lower Bollinger Band 0.5372
Percent B (%b) 0.12
BandWidth 18.329388
MACD Line -0.0195
MACD Signal Line -0.0167
MACD Histogram -0.0028
Fundamentals Value
Market Cap 70.54 Million
Num Shares 128 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -3.35
Price-to-Sales 0.00
Price-to-Book 21.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.60
Resistance 3 (R3) 0.60 0.58 0.59
Resistance 2 (R2) 0.58 0.57 0.58 0.58
Resistance 1 (R1) 0.57 0.56 0.56 0.57 0.58
Pivot Point 0.55 0.55 0.55 0.55 0.55
Support 1 (S1) 0.54 0.54 0.53 0.54 0.52
Support 2 (S2) 0.52 0.53 0.52 0.52
Support 3 (S3) 0.51 0.52 0.51
Support 4 (S4) 0.51